Factors associated with frovatriptan response in patients with migraine: A prospective, observational study

Conclusions Depression may be a risk factor of frovatriptan inefficacy in patients with migraine, even though half of patients with major depressive disorder respond to frovatriptan.

http://cep.sagepub.com/cgi/content/abstract/36/5/493?rss=1

Source: Cephalalgia - April 20, 2016 Category: Neurology Authors: Seo, J.-G., Park, S.-P. Tags: Brief Report Source Type: research